Holtec Nuclear Corporation has filed a public S-1 registration with the U.S. Securities and Exchange Commission to launch an initial public offering on Nasdaq under the ticker HNUC. The proceeds from the IPO will support the company’s push to develop its SMR-300 small modular reactors, which promise faster construction and lower costs compared to traditional nuclear plants.
Founded in 1986 and based in Camden, New Jersey, Holtec is a global supplier of technologies to over 140 nuclear facilities across 18 countries. Along with manufacturing systems and equipment, Holtec manages spent nuclear fuel and focuses heavily on advancing SMR technology as a strategic growth area. The company’s IPO is backed by prominent underwriters, including J.P. Morgan, Goldman Sachs, Guggenheim Securities, and Citigroup.
A significant aspect of Holtec’s expansion hinges on Palisades, a nuclear plant in Michigan that ceased operations in 2022 after more than 50 years. Holtec submitted licensing requests in late 2023 to restart the facility, with major approvals granted by the Nuclear Regulatory Commission in 2025, though further assessments remain before Palisades can resume operations under its current license—valid through 2031.
Complementing regulatory progress, the U.S. Department of Energy provided a $1.52 billion loan guarantee in September 2024 to aid Palisades’ restoration and later committed $400 million in December 2025 for two SMR-300 units to be built on-site. This funding covers licensing, pre-construction preparations, and mobilizing the supply chain for the dual reactor project. Michigan’s governor highlighted the investment’s potential to double Palisades’ output, powering an estimated 1.4 million homes and businesses.
The IPO arrives amid a strong market for new public listings, with Nasdaq reporting a record first half of 2026 by capital raised. Increased demand for electricity driven by booming data centers, electric vehicles, and crypto mining has elevated investor interest in energy infrastructure, bolstering Holtec’s timing to expand its advanced nuclear offerings.